Why did Novartis get a reward for new NTD treatments and vaccines even though the drug has been used for 30 years? Because of loopholes in the #PRV program requirements. US #Congress can & should fix this. Stop this misuse and better incentivize urgently needed R&D for NTDs
05:39 - 14 Feb 2019